SLIDE 1
p pp
Simcere Pharmaceutical Group Simcere Pharmaceutical Group
CIBC The China Dragon Call Conference, May 2007
EARNEST\roadshow presentation\simcere roadshow v27.ppt
Disclaimer
THE SLIDES USED IN THIS PRESENTATION ARE STRICTLY CONFIDENTIAL AND HAVE BEEN PREPARED BY SIMCERE PHARMACEUTICAL GROUP (THE “COMPANY”) SOLELY FOR USE AS A SUPPORT FOR ORAL DISCUSSIONS AT THE ROADSHOW PRESENTATION. THEY MAY NOT BE DISTRIBUTED, REPRODUCED, RE-DISTRIBUTED OR PASSED ON, DIRECTLY OR INDIRECTLY, TO ANY PERSON OR PUBLISHED, IN WHOLE OR IN PART, FOR ANY PURPOSE. NO PART OF THESE SLIDES MAY BE RETAINED FOLLOWING THIS ROADSHOW PRESENTATION OR DISTRIBUTED, TAKEN OR TRANSMITTED INTO THE UNITED STATES, CANADA OR JAPAN. THE DISTRIBUTION OF THE SLIDES IN OTHER JURISDICTIONS MAY BE RESTRICTED BY LAW. BY PARTICIPATING IN THIS PRESENTATION, YOU AGREE TO BE BOUND BY THE FOREGOING LIMITATIONS. The information contained in this presentation does not constitute or form part of any offer for sale or subscription of or solicitation or invitation of any offer to buy or subscribe for any securities nor shall it or any part of it form the basis of or be relied on in connection with any contract or commitment
- whatsoever. No securities of the Company may be sold in the United States without registration with the United States Securities and Exchange
Commission (the “SEC”) or an exemption from such registration. The Company has filed a registration statement for the securities to be offered in the United States. Any public offering of the securities to be made in the United States will be made solely by means of the prospectus in the registration
- statement. The prospectus will contain detailed information about the Company and its management as well as the financial statements of the Company.
Any decision to purchase shares in the offering for sale in the United States or anywhere else should be made solely on the basis of the information contained in the prospectus. This presentation does not contain all relevant information relating to the Company or its securities, particularly with respect to the risks and special considerations involved with an investment in the securities of the Company, and is qualified in its entirety by reference to the detailed information appearing in the prospectus. This presentation may contain forward-looking statements, including statements about our business outlook, our strategy and market opportunity, and statements about our historical results that may suggest trends for our business. These statements are individually and collectively forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward- looking statements are made only as of the date of this presentation and the Company undertakes no obligation to update or revise. These statements are based on estimates and information available to us at the time of this presentation and are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Therefore, prospective investors are cautioned that actual results may differ materially from those set forth in any forward-looking statements herein. The information contained in these slides has not been independently verified. No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of any information or opinion contained herein. The information contained in these slides should be considered in the context of the circumstances prevailing at the time and has not been, and will not be, updated to reflect material developments which may occur after the date of the presentation. None of the Company, any underwriter of securities of the Company, or any of their respective directors, officers, employees, agents or advisers shall be in any way responsible for the contents hereof, or shall be liable for any loss arising from use of the information contained in this presentation or otherwise arising in connection therewith. The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling toll-free 1-866-471-2526